Thrombocytopenia Clinical Trials in Beijing, Beijing Municipality
12 recruitingBeijing, Beijing Municipality, China
Showing 1–12 of 12 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Thrombocytopenia Associated With Chronic Liver Disease
Chongqing Peg-Bio Biopharm Co., Ltd.54 enrolled8 locationsNCT07446491
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd.56 enrolled7 locationsNCT06929299
Recruiting
Phase 1
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
CancerThrombocytopenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences16 enrolled1 locationNCT07110090
Recruiting
Phase 2
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
Immune Thrombocytopenia (ITP)
Peking University People's Hospital132 enrolled3 locationsNCT07065968
Recruiting
Phase 1
Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia
Autoimmune Thrombocytopenia
Juventas Cell Therapy Ltd.12 enrolled1 locationNCT06826430
Recruiting
Phase 1
A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
Lupus Nephritis (LN)Immune Thrombocytopenia (ITP)
China Immunotech (Beijing) Biotechnology Co., Ltd.36 enrolled1 locationNCT06943937
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
ThrombophiliaThrombosisArterial Thromboembolism+13 more
Peking University People's Hospital3,000 enrolled5 locationsNCT06727669
Recruiting
Phase 2Phase 3
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
ThrombocytopeniaStem Cell Transplant Complications
Peking University People's Hospital142 enrolled14 locationsNCT06202625
Recruiting
Phase 2
Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy
Immune Thrombocytopenia
Peking University People's Hospital100 enrolled1 locationNCT06577909
Recruiting
Phase 2
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
Immune Thrombocytopenia
Peking Union Medical College Hospital56 enrolled1 locationNCT06478537
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856